S-Ventures PLC Arrangement of Loan Facility (4189S)
November 06 2023 - 2:00AM
UK Regulatory
TIDMSVEN
RNS Number : 4189S
S-Ventures PLC
06 November 2023
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES
OF THE MARKET ABUSE REGULATION (EU) 596/2014 WHICH FORMS PART OF UK
LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018 ("UK
MAR"). IN ADDITION, MARKET SOUNDINGS (AS DEFINED IN UK MAR) WERE
TAKEN IN RESPECT OF CERTAIN OF THE MATTERS CONTAINED IN THIS
ANNOUNCEMENT, WITH THE RESULT THAT CERTAIN PERSONS BECAME AWARE OF
SUCH INSIDE INFORMATION, AS PERMITTED BY UK MAR. UPON THE
PUBLICATION OF THIS ANNOUNCEMENT, THIS INSIDE INFORMATION IS NOW
CONSIDERED TO BE IN THE PUBLIC DOMAIN AND SUCH PERSONS SHALL
THEREFORE CEASE TO BE IN POSSESSION OF INSIDE INFORMATION.
S-Ventures PLC
("S-Ventures" or the "Group")
Arrangement of Loan Facility
S-Ventures (AQSE: SVEN), the company investing in brands across
the natural, wellness and food-tech categories, is pleased to
announce that the Group has secured a bridging loan facility of
GBP1m, which is predominantly for short-term working capital
purposes and will be repayable in six months. The facility has been
secured through a Middle Eastern family office and enables
S-Ventures to secure working capital as it works through its
fundraise plans and process. The facility is in two tranches of
GBP500,000. The first tranche has been made available and the
second tranche will be available on 6 November 2023. The facility
bears an interest rate of 2 per cent. per month and has been
secured by a debenture, and is also supported by a personal
guarantee from S-Venture's CEO, Scott Livingston.
We expect to update the market on the fundraise announced on
18th October in due course.
For further information, please contact:
S-Ventures plc
Scott Livingston (Chief Executive
Officer) +44 (0) 1932 400 224
Stephen Argent (Chief Financial
Officer)
VSA Capital, AQSE Corporate
Adviser and Broker:
Andrew Raca
Matt Harker +44 (0) 20 3005 5000
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NEXNKABDBBDKPDK
(END) Dow Jones Newswires
November 06, 2023 02:00 ET (07:00 GMT)
SVentures (AQSE:SVEN)
Historical Stock Chart
From Oct 2024 to Nov 2024
SVentures (AQSE:SVEN)
Historical Stock Chart
From Nov 2023 to Nov 2024